Evoked potentials monitoring in Parkinson's disease therapy

Author： Stanzione P. Pierantozzi M. Semprini R. Traversa R. Bernardi G.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 233-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Electrophysiological monitoring of dopaminergic therapy using short-latency median nerve somatosensory evoked potentials (SEPS) in Parkinson's disease

By Mauguiegrave re F.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 234-234

Elsevier

Access to resources Recommend Favorite

Apomorphine therapy in Parkinson's disease: a review

By Ul Haq Ihtsham Lewitt Peter A Fernandez Hubert H

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2799-2809

Informa Healthcare

Access to resources Recommend Favorite

Transplantation therapy for Parkinson’s disease

By Borlongan C.V.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2319-2330

Informa Healthcare

Access to resources Recommend Favorite

Entacapone adjunctive therapy clear choice in Parkinson's disease

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Istradefylline effective adjunct therapy for Parkinson's disease

Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite